Related Experiment Videos
Management of high-risk melanoma
P Bonaccorsi1, J C Ansel, C A Armstrong
1Department of Dermatology, Emory University School of Medicine, Veterans Affairs Medical Center, Atlanta, Georgia, USA.
Dermatologic Clinics
|November 14, 2001
Summary
Developing new treatments for high-risk melanoma is crucial. Combining surgery, chemotherapy, immunotherapy, and radiation therapy shows promise for better patient outcomes in advanced melanoma care.
Area of Science:
- Oncology
- Dermatology
Background:
- High-risk melanoma necessitates improved treatment strategies.
- Current therapies show limited response rates for advanced melanoma.
- Melanoma treatment is expanding beyond skin-limited disease.
Purpose of the Study:
- To explore innovative and concurrent treatment modalities for high-risk melanoma.
- To address the need for more effective melanoma management beyond the skin.
Main Methods:
- Investigating the combined application of surgery, chemotherapy, immunotherapy, and radiation therapy.
- Evaluating treatment efficacy in patients with advanced or metastatic melanoma.
Main Results:
- Concurrent multimodal therapy demonstrates potential for enhanced patient outcomes.
- Further research is warranted to optimize combination treatment protocols.
Conclusions:
- Multimodal treatment approaches, including surgery, chemotherapy, immunotherapy, and radiation, offer significant promise.
- Continued investigation is vital for advancing the management of devastating melanoma cases.